機器人手術對婦科腫瘤學的影響

The Impact of Robotic Surgery on Gynecologic Oncology

機器人手術系統的引入，代表了婦科微創手術的典範轉移。透過3D立體視野、EndoWrist技術與濾除手顫功能，機器人平台克服了傳統腹腔鏡視野受限與操作僵硬的局限，使複雜的腫瘤手術更具可行性。在臨床應用上，其角色隨癌別而異：於子宮內膜癌，機器人手術已成為標準治療，特別是在肥胖病人與前哨淋巴結，顯影技術上展現顯著優勢；然而，受LACC試驗（laparoscopic approach to cervical cancer trial，早期子宮頸癌腹腔鏡手術對比研究）影響，早期子宮頸癌的治療，回歸以開腹手術為主，但在低風險族群與改良術式上的應用，仍存探討空間；針對卵巢癌，目前主要應用於早期分期與經篩選後的間歇性減積手術。在經濟層面，儘管設備成本高昂，但在高病人量醫學中心，可透過縮短住院天數與降低併發症，達到與開腹手術相當的成本效益。此外，機器人系統直觀的操作介面，雖縮短了學習曲線，但缺乏觸覺回饋，仍是需透過視覺代償與模擬訓練克服的挑戰。未來，隨著單孔（single-port，SP）手術、影像導引與AI輔助技術的整合，機器人手術將朝向極致微創與精準醫療邁進，持續優化婦癌病人的手術預後。

The advent of robotic surgery represents a significant paradigm shift in gynecologic oncology. By offering high-resolution 3D visualization, EndoWrist instrumentation, and tremor filtration, robotic platforms have overcome the limitations of conventional laparoscopy, such as restricted depth perception and rigid ergonomics. Clinically, the impact varies by malignancy. In endometrial cancer, robotic surgery has become the standard of care, demonstrating superior utility in obese patients and sentinel lymph node mapping. Conversely, the landscape for early-stage cervical cancer was reshaped by the LACC trial, favoring open surgery, although its role in low-risk subgroups and modified techniques remains under investigation. For ovarian cancer, its application is currently focused on early-stage staging and selected interval debulking surgeries. Economically, while initial acquisition costs are high, high-volume centers can achieve cost-effectiveness comparable to open surgery through reduced lengths of stay and lower complication rates. Regarding training, the platform’s intuitive interface shortens the learning curve compared to laparoscopy, though the lack of haptic feedback necessitates reliance on visual cues and simulation training. Looking forward, the integration of single-port (SP) systems, augmented reality image guidance, and artificial intelligence promises to further refine surgical precision and personalize patient care in the era of precision medicine.